NCT02033057

Brief Summary

Even 20-50% of patients under sedation and mechanical ventilation develops myopathy and / or neuropathy which difficulties both the process of extubation and the functional recovery. The objective of this project is to analyze the effect of muscle electrostimulation (ESM) on muscle weakness acquired in Intensive Care Unit (ICU) and its consequences. Study design: a single center, prospective, randomized trial to be held in the ICU of " Universitarian hospital La Fe" in collaboration with the service of Neurophysiology of the hospital. All patients undergoing sedation and mechanical ventilation (with an expected duration longer than 48h) and without any of the exclusion criteria detailed in the Methodology section will be included in the study. The intervention will consist of a muscular electrostimulation with the Super Pro Excel 70,UltratoneTM. The stimulation will be performed in 10 muscle groups (5 per side) following established protocols, at least 5 days a week. We will evaluate muscle strength by Medical Research Council scale, functional capacity by Barthel scale and Neurophaty Disability Scale, all clinical events will be collected and electrophysiologic, echographic and histologic parameters will be measured. The process of extubation will be performed following an established protocol, the duration will be collected as the same manner as ICU.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 8, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 10, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

January 10, 2014

Status Verified

October 1, 2012

Enrollment Period

2 years

First QC Date

January 8, 2014

Last Update Submit

January 9, 2014

Conditions

Keywords

Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.

Outcome Measures

Primary Outcomes (1)

  • muscular weakness

    We measure the muscular weakness, with the medical research council scale.

    at the time of weaning, 30 days after extubation and one year after extubation.

Secondary Outcomes (1)

  • time of weaning

    everyday

Study Arms (1)

Muscular electrostimulation.

EXPERIMENTAL

The interventions is muscular electrostimulation.

Procedure: Muscular electrostimulation and percutaneus muscular biopsy.

Interventions

Muscular electrostimulation everyday and percutaneus muscular biopsy weekly.

Muscular electrostimulation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years.
  • Sedated and mechanically ventilated critically ill patients, more than 48 hours.

You may not qualify if:

  • Body mass index \> 45 or \< 20 kg/m2.
  • Pregnant.
  • Epilepsia.
  • Use muscular blocks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario y Politécnico La Fe.

Valencia, Valencia, 46026, Spain

RECRUITING

MeSH Terms

Conditions

PolyneuropathiesMuscle Weakness

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

January 8, 2014

First Posted

January 10, 2014

Study Start

October 1, 2012

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

January 10, 2014

Record last verified: 2012-10

Locations